FP6Individual fellowship2006–2008

GLU_NEUROSENSOR · Fluorescent imaging of glutamate: a powerful tool for the comprehension of neurodegenerative diseases

FP6 — Marie Curie Actions (Human Resources and Mobility)

Duration
2006-12-01 → 2008-11-30
EU contribution
€149,670
Participants
1
Scheme
EIF

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Results in brief

Final Activity Report Summary - GLU_NEUROSENSOR (Fluorescent imaging of glutamate: a powerful tool for the comprehension of neurodegenerative diseases)

L-Glutamate is the most abundant neurotransmitter present in mammalian brain. This amino acid accomplishes essential functions inside the central nervous system (CNS): its movement across the neuronal synapses ensures the regulation of our locomotive and physiological activity and also regulates superior intellectual activity such as affectivity and moods. An alteration of its capacity in sending stimuli between neurons induces great damages of the cerebral structure and consequently neurological disorders. Clinical studies have evidenced that an increase in L-Glutamate concentration is directly linked with the appearance of neurodegenerative diseases such as Parkinson, Alzheimer, Huntington, dementia, amyotrophic lateral sclerosis (ASL). In this context, the project aims to synthesise fluorescent molecular tools able to make L-Glutamate detectable by fluorescence imaging microscopy in order to visualise its mobility and distribution directly in living cells. Two strategies have been overcome for the realisation of these fluorescent molecular sensing tools: - Strategies A: The synthesis of a fluorescent L-Glutamate derivative for determining the mobility and the distribution of this neurotransmitter directly in neurons. This new fluorescent neurotransmiiter has to be internalized in living cells as the natural glutamate is. This is why we had, during the fellowship, to synthesised four fluorescent L-Glutamate derivatives. We marked L-Glutamate in different positions and with three different fluorophores in order to enlarge the probability of success for the cellular up-take. The most promising molecule will now be tested on living neuronal cells in the neurobiologists group we collaborate with. - Strategies B: The synthesis of a selective luminescent biosensor for L-Glutamate in extracellular space, in other words a selective supramolecular receptor for L-Glutamate that signals the presence of L- Glutamate with a change in luminescence emission of the probe but with no modification of the neurotransmitter. Three tris-bipyridyl Ruthenium complexes with a bipyridine modified in 3,3'-position were synthesised. The 3,3'-modified pyridine possess arms with guanidinium functions able to recognise and detect the glutamate in photoluminescence. Moreover, these ruthenium complexes are able to discriminate L-Glutamate and phosphate anions (abundantly presents in cellular milieu) depending of the detection method, photoluminescence or electrochemiluminescence. That's important for preventing interferences in detecting L-Glutamate directly in neuronal tissue. These ruthenium complexes could be good candidates for building sensors made by optical fibres that present a face with a deposed polymer doped with our complexes. This kind of sensor could permit our complexes perform remote real-time imaging.

Data: CORDIS, © European Union

Project objective

This Project aims at synthesising powerful chemical tools that make the neurotransmitter L-glutamate (L-Glu) detectable by fluorescence spectroscopy and permit to study its mobility, distribution and concentration in living cells with fluorescent microscopy, thus strongly contributing to the study of biologists and physiopathologists on neurological diseases in which this neurotransmitter seems to play an important role. L-Glu is the most abundant neurotransmitter of the excitatory synapses in the Central Nervous System (CNS). It is fundamental in the regulation and modulation of the CNS, in the regulation of the locomotive and physiological activity, in superior intellectual activity, and in affectivity and moods. Clinical studies have evidenced that metabolic damages of L-Glu are responsible of neurological and degenerative illnesses such as Parkinson, Alzheimer, Huntington, dementia, amyotrophic lateral sclerosis (ASL): in these pathologies L-Glu accumulates in extra-cellular space and becomes toxic for neurons. It is needed to investigate distribution and concentration of L-Glu directly in living cells but, the techniques available today, microdialyse and capillary electrophores, damage the living tissue. Fluorescence microscopy does not cause damages and provides sensitivity, selectivity and versatility but, L-Glu is not fluorescent by itself. In order to study it with fluorescent imaging techniques, we will synthesise chemical tools as: -a fluorescent L-Glu derivative: a synthetic molecule that can be inserted inside the cells and whose diffusion and distribution can be followed by imaging technique;-a fluorescent probe for L-Glu: selective receptors of L-Glu for determining distribution and concentration of L-Glu in extracellular space.The applicant, dr. Berni, and the Lacrem laboratory together can provide the multidisciplinary knowledge necessary to realise the Project: coordination chemistry, photo-physics, organic synthesis, analytical techniques.

Original text from CORDIS.

Participants

  • ECOLE NATIONALE SUPERIEURE DE CHIMIE ET DE PHYSIQUE DE BORDEAUX · PESSACCoordinatorCity levelFrance

Links

Data: CORDIS, © European Union